Granted Patent B2

US 9,668,993 · App. 12/796,889 · Granted Jun 6, 2017

Abstract

Claims (23)

1. A method of administering a non-steroidal anti-inflammatory drug, which consists of providing to a mammal a dosage form comprising an initial dose of an immediate release portion containing said non-steroidal anti-inflammatory drug and a second dose of a delayed burst release portion containing said non-steroidal anti-inflammatory drug that is released about 4 hours after administration of said initial dose, said non-steroidal anti-inflammatory drug having a duration of therapeutic effect which lasts at least about 6 hours after administration of said second dose, wherein said initial dose is at least about twice said second dose.

2. The method of claim 1 , wherein said initial dose is about 5 mg/kg to about 12 mg/kg and said second dose is about 2.9 mg/kg to about 6 mg/kg.

3. The method of claim 1 , wherein said non-steroidal anti-inflammatory drug is a propionic acid derivative.

4. The method of claim 3 , wherein said propionic acid derivative is selected from the group consisting of ibuprofen, naproxen, benoxaprofen, naproxen sodium, flurbiprofen, fenoprofen, fenbuprofen, ketoprofen, indoprofen, pirprofen, carpofen, oxaprofen, pranoprofen, microprofen, tioxaprofen, suproprofen, alminoprofen, tiaprofenic acid, fluprofen and bucloxic acid.

5. The method of claim 4 , wherein said propionic acid derivative is ibuprofen.

6. The method of claim 1 , wherein said initial dose and said second dose are administered to the mammal in separate dosage forms.

7. The method of claim 1 , wherein said dosage form is a solid dosage form.

8. The method of claim 1 , wherein said therapeutic effect is pain relief.

9. A method of administering a propionic acid derivative to a mammal, over a 12-hour time period, which comprises providing a dosage form comprising an initial dose of an immediate release portion and a second dose of a delayed burst release portion of said propionic acid derivative to said mammal, wherein said dosage form provides a first peak plasma concentration of said propionic acid derivative of about 25 to about 30 mcg/mL in said mammal about 30 to about 120 minutes after said initial dose, and a second peak plasma concentration of said propionic acid derivative of about 15 to about 30 mcg/mL about 45 to about 5.5 hours after administration of said initial dose.

10. The method of claim 9 , wherein the plasma concentration in said mammal at about 10 hours after administration of the initial dose is less than about 10 mcg/mL.

11. A method of administering a propionic acid derivative, which comprises providing to a mammal, over a 12 hour time period, a dosage form comprising an initial dose of an immediate release portion and a second dose of a delayed burst release portion of said propionic acid derivative, wherein said initial dose of said propionic acid derivative is released at the beginning of said 12 hour time period, followed by said second dose of said propionic acid derivative about 4 hours after administration of said initial dose, wherein said initial dose is at least about twice said second dose and no further propionic acid derivative is provided during said 12 hour time period.

12. The method of claim 11 , wherein said propionic acid derivative is ibuprofen.

13. The method of claim 11 , wherein said initial dose is about 400 nag and said second dose is about 200 mg.

14. A method of administering acetaminophen, which consists of providing to a mammal a dosage form comprising an initial dose of an immediate release portion and a second dose of a delayed burst release portion of said acetaminophen, wherein said initial dose of acetaminophen is followed by said second dose of acetaminophen about 4 hours after administration of said initial dose, said acetaminophen having a duration of therapeutic effect which lasts at least about 6 hours after administration of said second dose.

15. The method of claim 14 , wherein said second dose is at least about twice said first dose.

16. The method of claim 14 , wherein said second dose is administered about 4 hours after said initial dose.

17. The method of claim 14 , wherein said initial dose and said second dose are administered to the mammal in separate dosage forms.

18. The method of claim 14 , wherein said dosage form is a solid dosage form.

19. The method of claim 14 , wherein said therapeutic effect is pain relief.

20. A method of administering acetaminophen, which comprises providing to a mammal, over a 12 hour time period, a dosage form comprising an initial dose of an immediate release portion and a second dose of a delayed burst release portion of said acetaminophen, wherein said initial dose of acetaminophen at the beginning of said 12 hour time period, is followed by said second dose of acetaminophen about 4 hours after administration of said initial dose, wherein said initial dose is at least about twice said second dose and no further acetaminophen is provided during said 12 hour time period.

21. A method of reducing drug exposure of a mammal to an NSAID comprising providing said NSAID to said mammal using the method of claim 1 .

22. A method of administering a therapeutic agent, which consists of providing to a mammal a dosage form comprising an initial dose of an immediate release portion of a non-steroidal anti-inflammatory drug and a second dose of a delayed burst release portion of acetaminophen, wherein said initial dose of said non-steroidal anti-inflammatory drug is followed by said second dose of acetaminophen about 4 hours after administration of said initial dose of non-steroidal anti-inflammatory drug; said non-steroidal anti-inflammatory drug and acetaminophen having a combined duration of therapeutic analgesic effect which lasts at least about 6 hours after administration of said second dose of acetaminophen.

23. A method of reducing drug exposure of a mammal to an NSAID comprising providing said NSAID to said mammal using the method of claim 9 .

Assignments (7)